Nerve regeneration research method based on nerve fiber specific fluorescence
By inserting fluorescent protein-encoded genes into the animal genome and performing neural damage modeling, using biofluorescence three-dimensional imaging technology, the existing neural regeneration detection methods are solved, and three-dimensional stereoscopic imaging and effectiveness of neural regeneration tissues are achieved Sexual assessment.
Patent Information
- Application Number
- CN202411081848.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-15
AI Technical Summary
The existing visual detection methods for neural regeneration have problems such as poor specificity, low depth and high cost, making it difficult to comprehensively and accurately evaluate the effectiveness of neural repair methods.
By inserting the fluorescent protein-encoding gene into the Nefh gene promoter of the animal genome, animals expressing fluorescent proteins are constructed, nerve damage modeling and repairing, and then three-dimensional stereo imaging of nerve regenerated tissue is achieved through biofluorescence three-dimensional imaging.
The manifestation of nerve fiber-specific fluorescence signals can be achieved, and the effectiveness of neural repair methods can be comprehensively and accurately evaluated, avoiding the tedious workload of traditional methods and non-specific fluorescence interference, and providing a more comprehensive regenerative neural tissue research plan.
Smart Images

Figure CN118956977A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical technology, and in particular relates to a nerve regeneration research method based on nerve fiber-specific fluorescence. Background Art
[0002] Nerves include spinal cord and peripheral nerves. The spinal cord is located inside the spine and is protected by the vertebrae; it is an extension of the central nervous system originating from the brain. The cells of the central nervous system rely on complex connections to process and transmit information. The spinal cord is mainly responsible for the reflex actions of the trunk and limbs, and for transmitting nerve information between the brain and the periphery. Peripheral nerves refer to all nerves outside the brain and spinal cord, including ganglia, nerve trunks, nerve plexuses and nerve terminal devices; peripheral nerves can be divided into cranial nerves connected to the brain and spinal nerves connected to the spinal cord according to the different parts of the connection to the center. The extension of the cytoplasm (cytoplasm) of neurons is called a "nerve fiber", also called a "process".
[0003] However, nerves can be divided into the following types according to the degree of injury: nerve injury causes temporary obstruction of nerve function conduction, which in turn leads to non-degeneration of nerve fibers. The clinical manifestations are movement disorders without muscle atrophy, persistent pain, and does not disappear. The function can recover on its own within a few days or weeks without sequelae; axonal rupture: the nerve is bluntly injured or continuously compressed, and the axonal rupture leads to degeneration of the distal axon and myelin sheath. The endoneurium tube is intact, and the axon can grow along the end of the neurothecal tube. The clinical manifestations are loss of motor and sensory function, muscle atrophy and the end of nutritional changes in the nerve distribution. In most cases, it can recover on its own. In severe cases, scar formation within the nerve requires neurolysis; and complete nerve rupture and complete loss of nerve function require surgical repair to restore function.
[0004] After nerve damage is repaired, the regenerated nerve tissue needs to be visualized. Traditional methods for visualizing regenerated nerves include slice observation and detection based on fluorescent marker antibodies. Among them, paraffin sections / frozen sections (5-25μm thin slices) and immunohistochemical fluorescence. This scheme usually consumes a lot of researchers' energy, and it is difficult to reconstruct three-dimensional tissues with thin slices. The final effect is unsatisfactory and cannot fully reflect the regeneration of the entire organ dimension. Another method is to combine tissue transparency with antibodies pre-linked to fluorescent markers throughout the regenerated nerve tissue. Due to the limited penetration efficiency of antibodies, this method has low tissue depth and poor specificity. At the same time, this technology requires incubation with a primary antibody pre-linked to a fluorescent group to avoid repeated incubation of fluorescent secondary antibodies that are difficult to wash off. Non-specific fluorescence, therefore, limits the choice of antibody markers. Only a few commonly used pre-coupled antibodies are available on the market, and they are expensive. Summary of the invention
[0005] In view of this, the purpose of the present invention is to provide a nerve regeneration research method based on nerve fiber-specific fluorescence, which not only realizes specific nerve axon fluorescence signals, but also realizes three-dimensional stereoscopic imaging of regenerated nerve tissue based on the fluorescence signals, so as to comprehensively and accurately evaluate the effectiveness of nerve repair measures.
[0006] The present invention provides a method for evaluating nerve regeneration based on nerve fiber-specific fluorescence, comprising the following steps:
[0007] After inserting the fluorescent protein encoding gene into the Nefh gene promoter of the animal genome, an animal expressing the fluorescent protein was constructed;
[0008] Performing nerve injury modeling on the animal expressing the fluorescent protein, and performing repair and regeneration to obtain an animal with nerve regeneration;
[0009] taking regenerated nerve tissue from the animal undergoing nerve regeneration, fixing the regenerated nerve tissue, and subjecting the regenerated nerve tissue to transparent treatment to obtain a pre-treated material;
[0010] The pretreated material is subjected to bioluminescent three-dimensional imaging to obtain a three-dimensional stereogram of the regenerated nerve tissue.
[0011] Preferably, the method for constructing the animal expressing the fluorescent protein comprises constructing a recombinant Donor vector expressing the fluorescent protein;
[0012] Microinjecting the recombinant Donor vector into the nucleus of the fertilized egg to obtain a recombinant fertilized egg;
[0013] Transplanting the recombinant fertilized eggs into animals via embryos, raising and giving birth to obtain F0 animals expressing fluorescent protein;
[0014] The F0 animals expressing the fluorescent protein are mated and passaged to obtain homozygous offspring animals expressing the fluorescent protein.
[0015] Preferably, the fluorescent protein includes at least one of the following: green fluorescent protein, red fluorescent protein and orange fluorescent protein.
[0016] Preferably, the nucleotide sequence of the recombinant Donor vector is obtained by concatenating SEQ ID NO: 1 and SEQ ID NO: 2.
[0017] Preferably, the animal expressing the fluorescent protein also includes PCR identification;
[0018] The PCR identification primers include primer pair 1 and primer pair 2;
[0019] The primer pair 1 comprises a forward primer having a nucleotide sequence as shown in SEQ ID NO: 3 and a reverse primer having a nucleotide sequence as shown in SEQ ID NO: 4;
[0020] The primer pair 2 includes a forward primer having a nucleotide sequence as shown in SEQ ID NO: 5 and a reverse primer having a nucleotide sequence as shown in SEQ ID NO: 6.
[0021] Preferably, the animal expressing the fluorescent protein includes a homozygous animal expressing the fluorescent protein and / or a heterozygous animal expressing the fluorescent protein.
[0022] Preferably, the method of fixing the regenerated nerve tissue from the animal with nerve regeneration is to perfuse the animal with paraformaldehyde, then peel off the skin, muscle and bone tissue under a microscope, and fix the regenerated nerve in paraformaldehyde.
[0023] Preferably, the nerve comprises the spinal cord and / or the sciatic nerve.
[0024] Preferably, the method of bioluminescent three-dimensional imaging uses a laser confocal microscope to perform z-axis multi-layer scanning on the pretreated material, and then uses ZEN software to perform three-dimensional reconstruction on the scanning results to obtain a nerve regeneration map.
[0025] Preferably, the animal comprises a mouse.
[0026] The present invention provides a method for evaluating nerve regeneration based on nerve fiber-specific fluorescence, comprising the following steps: inserting a fluorescent protein encoding gene into the Nefh gene promoter of an animal genome, constructing an animal expressing fluorescent protein; performing nerve injury modeling on the animal expressing fluorescent protein, and obtaining a nerve regenerating animal after recovery and growth; fixing the regenerated nerve tissue from the animal undergoing nerve regeneration, and making the regenerated nerve tissue transparent to obtain a pretreatment material; performing bioluminescent three-dimensional imaging on the pretreatment material to obtain a three-dimensional stereogram of the regenerated nerve tissue. The present invention uses fluorescent protein as a reporter protein to insert into the Nefh gene promoter of the animal genome, thereby giving mice excellent nerve fiber / axon-specific fluorescence properties. Nerve injury modeling is performed on animals that specifically express fluorescence in nerve fibers as research objects. After nerve recovery, regenerated nerves are taken from the research object, fixed, and the tissues are made transparent, thereby ensuring deep imaging of regenerated nerve tissue. The regenerated nerves treated with tissue transparency are subjected to three-dimensional bioluminescent imaging. Since the fluorescent signal is specifically displayed at the nerve axons, the regenerated nerve tissue can be reconstructed in three dimensions and the complete nerve regeneration picture can be reproduced, thereby judging whether the structure of the regenerated nerve has been restored to its original state, and thus evaluating the effectiveness of the nerve recovery method. It can be seen that the method provided by the present invention not only avoids the cumbersome and complicated workload brought by tissue sections and the nonspecific fluorescence interference brought by immunohistochemical fluorescence, but also can realize the regeneration research of any part of the nerve tissue, and is not limited by reagents, providing a more comprehensive technical solution for regenerative medicine researchers and a good research method for the clinical treatment of neurological diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 A flow chart of the nerve regeneration assessment method based on nerve fiber-specific fluorescence provided by the present invention;
[0028] Figure 2 This is a schematic diagram of the structure of the exogenous inserted gene fragment in the recombinant Donor vector of the present invention;
[0029] Figure 3 The spectrum of the recombinant Donor vector constructed in the present invention;
[0030] Figure 4 The vertical three-dimensional reconstruction effect diagram of normal spinal cord tissue; A is the imaging position and imaging effect diagram of the confocal lens; B is the X-axis and Y-axis section diagram after orthogonal processing of the imaging data; C and D are the observation result diagrams that can be rotated in any direction after three-dimensional reconstruction of the imaging data;
[0031] Figure 5A is a horizontal three-dimensional reconstruction effect diagram of normal spinal cord tissue; A is the imaging position and imaging effect diagram of the confocal lens; B is the X-axis and Y-axis section diagram after orthogonal processing of the imaging data; C is the observation result diagram of the three-dimensional reconstruction of the imaging data, which can be rotated in any direction; D is a 200-fold magnification of the target area for observation of the tissue;
[0032] Figure 6 This is a comparison of the results of section staining of the injured and regenerated area of homozygous mice 4 weeks after spinal cord injury modeling and tissue clearing imaging of fluorescent mice;
[0033] Figure 7 This is a comparison of the results of section staining of the injured and regenerated area in homozygous mice 4 weeks after sciatic nerve clamp injury and tissue clearing imaging of fluorescent mice;
[0034] Figure 8 The figures are the comparison results of direct fluorescence imaging and labeled antibodies of the spinal cord of homozygous mice, where A1 is a low-power image of a spinal cord cross section; B1 is a local enlarged image of the spinal cord cross section indicated by the yellow box in A1; A2 is a low-power image of the spinal cord cross section labeled with β-Tubulin III antibody with red fluorescence, and B2 is a local enlarged image of the spinal cord cross section indicated by the yellow box in A2. DETAILED DESCRIPTION
[0035] The present invention provides a method for evaluating nerve regeneration based on nerve fiber-specific fluorescence, comprising the following steps:
[0036] After inserting the fluorescent protein encoding gene into the Nefh gene promoter of the animal genome, an animal expressing the fluorescent protein was constructed;
[0037] Performing nerve injury modeling on the animal expressing the fluorescent protein, and performing repair and regeneration to obtain an animal with nerve regeneration;
[0038] taking regenerated nerve tissue from the animal undergoing nerve regeneration, fixing the regenerated nerve tissue, and subjecting the regenerated nerve tissue to transparent treatment to obtain a pre-treated material;
[0039] The pretreated material is subjected to bioluminescent three-dimensional imaging to obtain a three-dimensional stereogram of the regenerated nerve tissue.
[0040] The invention inserts the fluorescent protein coding gene into the Nefh gene promoter of the animal genome to construct an animal expressing the fluorescent protein.
[0041] The present invention does not impose any special restrictions on the types of animals, and any commonly used experimental animal species known in the art may be used, such as at least one of mice, rats, rabbits, dogs and monkeys. In the embodiments of the present invention, in order to illustrate the regenerative nerve evaluation method of the present invention, mice are used as experimental subjects for the experiment, but this should not be construed as limiting the scope of protection of the present invention. When the animal is a mouse, the nucleotide sequence of the Nefh gene promoter in the mouse genome is shown in SEQ ID NO: 7 ().
[0042] In the present invention, the fluorescent protein preferably includes at least one of the following: green fluorescent protein (eGFP), red fluorescent protein (mCherry) and orange fluorescent protein (ORPs). In the embodiment of the present invention, the application of the expression of fluorescent protein in the evaluation of regenerated nerves is illustrated by taking green fluorescent protein (eGFP) as an example. The nucleotide sequence of the gene encoding the green fluorescent protein (eGFP) is shown in SEQ ID NO: 8 ().
[0043] In the present invention, the method for constructing an animal expressing a fluorescent protein preferably includes constructing a recombinant Donor vector expressing a fluorescent protein; microinjecting the recombinant Donor vector into the nucleus of the fertilized egg to obtain a recombinant fertilized egg; transplanting the recombinant fertilized egg into an animal via embryo, raising and giving birth to obtain an F0 animal expressing a fluorescent protein; mating and passaging the F0 animal expressing a fluorescent protein to obtain an offspring animal expressing a fluorescent protein.
[0044] In the present invention, when constructing the recombinant Donor vector, the ROSA26 gene of the mouse is first used as a template to amplify the 5′ homology arm and the 3′ homology arm, and the “Nefh promoter-EGFP-rBG pA” expression cassette is reversely cloned into the intron 1 of the ROSA26 gene of the mouse, and the Nefh gene exon is inserted into the 5′ homology arm. The exogenous insertion fragment formed is 5′ homology arm-Nefh gene exon-5′ homology arm-rBG pA-EGFP-Nefh promoter-3′ homology arm. The nucleotide sequence of rBG pA is shown in SEQ ID NO: 9 (), which plays a role in terminating transcription. The exogenous insertion fragment also preferably includes an antibiotic gene fragment. The antibiotic gene fragment includes an ampicillin encoding gene and a kanamycin encoding gene. The nucleotide sequence of the exogenous insertion fragment is preferably as shown in SEQ ID NO: 1 to SEQ ID NO: 2. The recombinant Donor vector was commissioned to be constructed by Saiye Biotechnology Co., Ltd. When constructing genetically engineered mice, the recombinant Donor vector, gRNA and Cas9 enzyme are mixed and injected into fertilized eggs. The gRNA nucleotide sequence is preferably as shown in SEQ ID NO: 10. The construction of the genetically engineered mice is entrusted to Saiye Biotechnology Company.
[0045] The present invention has no special restrictions on the method of microinjection, and the microinjection method well known in the art can be used. The method for obtaining the fertilized egg is preferably to artificially induce labor in C57BL / 6J female mice, and the female mice after induction of labor mate with sexually mature male mice, and the fertilized eggs are collected from euthanized female mice the next day. The method of artificial induction of labor is to first inject 5-10IU / female mouse of pregnant mare serum (PMSG), and then inject 5-10IU / female mouse of chorionic gonadotropin (HCG), and the interval between the two is 46-48h. The fertilized egg is preferably cultured in a 5% CO2 environment at 37°C. The recombinant fertilized egg is preferably cultured in an M16 medium in a constant temperature 5% CO2 environment at 37°C for 0.5-1h or to 2 cells before transplantation, and transplantation is performed the next day. The transplant animal is preferably a pseudo-pregnant animal. The breeding is preferably 19-20d to give birth.
[0046] In the present invention, the F0 animal expressing fluorescent protein preferably also includes PCR identification. The primers for PCR identification preferably include primer pair 1 and primer pair 2. The primer pair 1 includes a forward primer with a nucleotide sequence as shown in SEQ ID NO: 2 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO: 3. The primer pair 2 includes a forward primer with a nucleotide sequence as shown in SEQ ID NO: 4 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO: 5. Based on the above PCR identification method, the length of the amplified band of wild-type mice is a band of 607 bp, and the homozygous mouse band is preferably a band of 387 bp. The heterozygous mouse band is preferably two bands of 387 bp and 607 bp.
[0047] In the present invention, the offspring animals expressing fluorescent protein preferably also include PCR identification; the primers for PCR identification preferably include primer pair 1 and primer pair 2. The primer pair 1 includes a forward primer with a nucleotide sequence as shown in SEQ ID NO: 2 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO: 3; the amplified product is 387bp. The primer pair 2 includes a forward primer with a nucleotide sequence as shown in SEQ ID NO: 4 and a reverse primer with a nucleotide sequence as shown in SEQ ID NO: 5, and the amplified product is 607bp. Based on the above PCR identification method, the length of the amplified band of wild-type mice is one band of 607bp, and the homozygous mouse band is preferably one band of 387bp. The heterozygous mouse band is preferably two bands of 387bp and 607bp. The offspring animals expressing fluorescent protein preferably include homozygous offspring animals expressing fluorescent protein and / or heterozygous offspring animals expressing fluorescent protein. The offspring animals expressing fluorescent protein include F1 generation and / or F2 generation.
[0048] After obtaining the animal expressing the fluorescent protein, the present invention performs nerve injury modeling on the animal expressing the fluorescent protein, and obtains an animal with nerve regeneration through repair and regeneration.
[0049] In the present invention, the method of nerve injury modeling is preferably a complete spinal cord transection injury and a sciatic nerve clamp injury. The method of recovery growth is preferably a natural recovery growth (without human intervention) or an interesting nerve injury repair treatment method. The recovery growth time is preferably 3 to 5 weeks, more preferably 4 weeks. The nerve preferably includes the spinal cord and / or the sciatic nerve.
[0050] After obtaining an animal with nerve regeneration, the present invention obtains regenerated nerve tissue from the animal with nerve regeneration, fixes it, and performs a transparent treatment on the regenerated nerve tissue to obtain a pre-treated material.
[0051] In the present invention, the method for fixing the regenerated nerve tissue from the animal with nerve regeneration is preferably to perfuse the animal with paraformaldehyde, then peel off the skin, muscle and bone tissue under a microscope, and fix the regenerated nerve in paraformaldehyde. The mass percentage of paraformaldehyde is preferably 4%.
[0052] In the present invention, the method for clearing the regenerated nerve is preferably completed using a tissue clearing kit (Cat. No.: T3740) produced by TCI. The main purpose of clearing the regenerated nerve is to make the regenerated nerve tissue transparent by minimizing light scattering and light absorption, thereby allowing deep imaging of large volumes of regenerated nerve tissue samples. When combined with a variety of molecular labeling methods and high-throughput optical sectioning microscopy, this technology can image the whole body and whole organs at cellular or subcellular resolution, providing detailed information on the complete biological system.
[0053] After obtaining the pre-treated material, the present invention performs bioluminescent three-dimensional imaging on the pre-treated material to obtain a three-dimensional stereogram of the regenerated nerve tissue.
[0054] In the present invention, the method of bioluminescence three-dimensional imaging preferably uses a laser confocal microscope to perform z-axis multi-layer scanning on the pretreated material, and then uses ZEN software to perform three-dimensional reconstruction of the scanning results to obtain a nerve regeneration map. In an embodiment of the present invention, the laser confocal microscope is a Zeiss laser confocal microscope.
[0055] In the present invention, the above method of the present invention is adopted, and animals with specific fluorescent genes of the nervous system are used as objects to reproduce the spatial distribution of nerve fibers in the regenerated spinal cord and the regenerated sciatic nerve, which can clearly show the fibrous structure of nerve axons and avoid the observation result of broken slices caused by the instability of the section effect. At the same time, the method provided by the present invention can realize three-dimensional stereoscopic imaging of regenerated nerve tissue, and all damaged area information is recorded in the same file. Researchers can select different levels for observation according to needs, which greatly improves the accuracy of the observation results.
[0056] The following is a detailed description of a nerve regeneration research method based on nerve fiber-specific fluorescence provided by the present invention in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0057] Example 1
[0058] A method for studying nerve regeneration based on nerve fiber-specific fluorescence
[0059] 1. Construction of genetically engineered mice
[0060] The present invention uses a gene knock-in method to specifically express green fluorescent protein (Enhanced Green Fluorescent Protein, EGFP) as a fluorescent reporter protein at the Nefh gene promoter of C57BL / 6J mice, thereby giving mice excellent nerve fiber / axon-specific fluorescence properties; F0 generation mice that specifically express fluorescent protein are used as parents for hybridization and passage, and F1 generation heterozygous (ROSA26_Nefh[KI / +]) male and female mice are selected for mating, and then the mouse tails are obtained, primers are designed, and the genotype of the F2 generation mice is identified by PCR technology. The resulting homozygous (ROSA26_Nefh[KI / KI]) and heterozygous (ROSA26_Nefh[KI / +]) can both show nerve axon-specific fluorescence. The genetically engineered mice were commissioned by Saiye Biotechnology Company to construct and obtain, and the specific steps are as follows:
[0061] 1. gRNA Design
[0062] Design gRNA for the Rosa26 safe site (NCBI Reference Sequence: NR_027008.1) at http: / / crispor.tefor.net / , and select gRNA with high score. The nucleotide sequence of gRNA: CTCCAGTCTTTCTAGAAGATGGG (SEQ ID NO: 10).
[0063] 2. Construction of recombinant Donor vector
[0064] Mouse BAC was used as a template to amplify the upstream homology arm (5'arm) and the downstream homology arm (3'arm). The Nefh gene sequence (Exon) was obtained by gene synthesis → ligation (backbone + fragment) / transformation → bacterial test → positive clones were extracted for plasmid → restriction enzyme digestion identification → sent for testing → preparation of injection plasmid (for the knock-in model, the "mouse Nefh promoter-EGFP-rBG pA" box was reversely cloned into the intron 1 of the mouse ROSA26 gene (see Figure 2 ), and a Kan resistance gene expression cassette and an Amp resistance gene expression cassette are also inserted. The clone position of the formed exogenous insertion fragment in the Donor vector is AsiS I / Nsi I. The exogenous insertion sequence is obtained by connecting SEQ ID NO: 1 and SEQ ID NO: 2 in series. The spectrum of the recombinant Donor vector is shown in Figure 3 .
[0065] 3.gRNA synthesis
[0066] gRNA: synthesized by GenScript; tracRNA: purchased from IDT.
[0067] 4. Preparation of RNP Complexes
[0068] Cas9 and gRNA were co-injected into fertilized eggs with the recombinant Donor vector constructed above to produce gene knock-in mice. Finally, the genotype of the newborn mice was identified by PCR and sequencing analysis.
[0069] 5. Preparation of Fertilized Eggs
[0070] Preparation of fertilized eggs: 3-4 week old C57BL / 6J female mice were selected and injected with 5-10 UI / mouse pregnant mare serum (PMSG) and 5-10 UI / mouse human chorionic gonadotropin (hCG), respectively, with an interval of 46-48 hours between the two.
[0071] After the HCG injection, the female mice were mated with adult fertile male mice to fertilize the female mice;
[0072] The next day, the female mice were euthanized, and the fertilized eggs were collected from the oviduct and placed in a 37°C 5% CO2 incubator for later use;
[0073] 6. Pronuclear Microinjection
[0074] Preparation of microinjection needles and fixation needles;
[0075] Add the prepared mRNA injection solution into the microinjection needle;
[0076] The fertilized eggs with normal morphology are selected and placed in the injection dish. Under an inverted microscope with a magnification of 200 to 400 times, the exogenous gene injection solution is injected into the nucleus of the fertilized egg by microinjection;
[0077] Transfer the injected fertilized eggs into M16 culture medium and place them in a 37°C constant temperature 5% CO2 incubator for 0.5 to 1 hour before transplantation; or culture them until they are 2 cells and transplant them the next day;
[0078] 7. Preparation of surrogate mice and embryo transplantation
[0079] Prepare pseudo-pregnant female mice: Select fertile female mice of appropriate age and mate them with male mice that have been sterilized after vasectomy to stimulate a series of pregnancy changes in the female mice to obtain pseudo-pregnant female mice, which will serve as surrogate mice for the transgenic fertilized eggs;
[0080] The fertilized eggs injected with foreign genes were transplanted into the oviduct of the surrogate mother mouse on the day of thrombosis;
[0081] After transplantation, place the surrogate mother mouse in a clean cage and keep it warm until it wakes up and then put it back in the cage for feeding;
[0082] After successful fallopian tube transplantation, the mother mouse will generally give birth 19 to 20 days after the operation;
[0083] One week after birth, the mice can be numbered by claw clipping and PCR identification can be performed at the same time; after 3 weeks of birth, the mice can be raised in separate cages;
[0084] 8. PCR Identification of F0 Mice Born
[0085] Collect tissues (tail or toe tissues) from 1-2 week old mice;
[0086] Lyse tissue and extract genome;
[0087] PCR amplification and electrophoresis detection were performed using specific primers for the target gene to screen out the offspring with the integration of the exogenous gene.
[0088] Primer design and horizontal electrophoresis performance are as follows: Primer pair 1: (annealing temperature 60.0℃)
[0089] F4: 5'-GTCGCTCTGAGTTGTTATCAGTAA-3' (SEQ ID NO: 3);
[0090] R4: 5'-TGCTGTCATTCCTTATTCCATAG-3' (SEQ ID NO: 4);
[0091] Length of PCR product: 387 bp.
[0092] Primer pair 2: (annealing temperature 60.0°C)
[0093] F3: 5'-AAGCCACGTTTCCGACTTGAGTTG-3' (SEQ ID NO: 5);
[0094] R3: 5'-GGGTGAGCATGTCTTTAATCTACC-3' (SEQ ID NO: 6);
[0095] Length of PCR product: 607 bp.
[0096] The reaction system for PCR amplification was 25 μl: ddH2O 9.0 μl, forward primer 1.0 μl, reverse primer 1 μl, Premix Taq 12.5 μl, and DNA template 1.5 μl.
[0097] Reaction program: 95°C for 3 min; 95°C for 15 s, 60°C for 15 s, 72°C for 60 s / kb, 35 cycles; 72°C for 5 min.
[0098] Judgment method: Wild-type mice: 1 band 607 bp;
[0099] Homozygous mice: 1 band, 387 bp;
[0100] Heterozygous mice: The two bands are 387 bp and 607 bp respectively.
[0101] Mice with integration are called founder mice and can be passaged and used to establish lines.
[0102] 9. Generation and establishment of transgenic mice
[0103] Mating and passage of mice carrying foreign genes with non-transgenic mice; each founder mouse needs to be passaged independently;
[0104] The F1 mice born were identified, and the offspring of the F0 mice that could be normally transmitted through the reproductive system had a 50% chance of carrying the integrated target gene;
[0105] The obtained F1 positive mice can be used for experiments and continued generation (they can also be bred with Cre mice);
[0106] If homozygous mice are needed, the positive F1 mice from the same source may be mated with each other. The probability of the F2 mice being homozygous is 25%.
[0107] Mice expressing the target gene will be screened out, and stable lineages will be established, while the lineage status and pedigree will be recorded.
[0108] 2. Construction of a genetically engineered mouse model of neural injury
[0109] The genetically engineered mice obtained above were subjected to injury treatment by complete spinal cord transection injury and sciatic nerve clamp injury, and were set aside after natural recovery and growth. The specific steps are as follows:
[0110] (1) Steps for modeling complete spinal cord transection injury:
[0111] 1. Surgical Preparation
[0112] Before surgery, experimental materials and tools need to be prepared, including 6-8 week old adult C57BL / 6 mice, isoflurane gas anesthesia apparatus, conventional surgical instruments, sterile surgical pads, and stereo microscopes. All instruments need to be sterilized, and the surgical microscope and operating table should be adjusted to the appropriate working position to ensure effective operation during surgery.
[0113] Anesthesia and restraint
[0114] The mouse was anesthetized using a gas anesthesia apparatus. After ensuring that it had no tail reflex and blink reflex, the mouse was fixed with its back facing up on the operating table on a constant temperature heating plate to ensure that the body temperature of the mouse was stable and fixed for surgical operation. The upper back was shaved and the skin was prepared.
[0115] Surgical Procedure
[0116] The skin on the back of the mouse was cut open in the T8 to T12 spinal region, the T9 vertebra was exposed and fixed, the lamina was removed with a rongeur, and then the spinal cord was transected with microsurgery scissors to ensure complete penetration to cause a complete transect injury. After flushing the surgical area with sterile saline and adequate hemostasis, the muscles and skin were sutured.
[0117] Postoperative Care
[0118] After surgery, the mice were moved to a warm and quiet environment, and their breathing and recovery were closely monitored while they were waiting for them to wake up. Three days after surgery, penicillin was injected and artificial urination was performed. The mice were checked for wound healing and signs of infection every day to ensure that they recovered well after surgery.
[0119] Precautions
[0120] The entire surgical process should be strictly sterile to prevent infection, and the mice's diet, activity, and excretion should be closely observed after surgery to ensure their good recovery. In addition, all experimental operations should comply with the regulations of the Animal Ethics Committee to minimize the pain of the animals.
[0121] (2) Sciatic nerve clamp injury modeling steps
[0122] 1. Surgical Preparation
[0123] Before surgery, experimental materials and tools need to be prepared, including 6-8 week old adult C57BL / 6 mice, isoflurane gas anesthesia apparatus, conventional surgical instruments, sterile surgical pads, and stereo microscopes. All instruments need to be sterilized, and the surgical microscope and operating table should be adjusted to the appropriate working position to ensure effective operation during surgery.
[0124] Anesthesia and restraint
[0125] The mouse was anesthetized using a gas anesthesia apparatus. After ensuring that it had no tail reflex and blink reflex, the mouse was fixed with its back facing up on the operating table on a constant temperature heating plate to ensure that the body temperature of the mouse was stable during the operation and that it was fixed for easy operation. The mouse legs were shaved and skinned.
[0126] Surgical Procedure
[0127] Make an incision in the thigh area of the mouse to expose the sciatic nerve, and carefully separate and remove the tissue covering the sciatic nerve with a glass needle. Use toothed forceps to clamp the sciatic nerve for 30 seconds until the epineurium is transparent but not severed, ensuring that the nerve tissue is clamped. Then carefully remove the clamp, check the condition of the nerve and surrounding tissue, and then suture the muscle and skin at the incision to ensure aseptic operation.
[0128] Postoperative Care
[0129] After surgery, the mice were moved to a warm and quiet environment, and their breathing and recovery were closely monitored while they were waiting to wake up. Penicillin was injected 3 days after surgery, and the mice were checked for wound healing and signs of infection every day to ensure that they recovered well after surgery.
[0130] Precautions
[0131] The entire surgical process should be strictly sterile to prevent infection, and the mice's diet, activity, and excretion should be closely observed after surgery to ensure their good recovery. In addition, all experimental operations should comply with the regulations of the Animal Ethics Committee to minimize the pain of the animals.
[0132] 3. Collection and Fixation of Nerve Tissue
[0133] After the homozygous mice were perfused and fixed with 4% paraformaldehyde, the skin, muscle and bone tissues were peeled off with conventional surgical instruments under a microscope, and the nerve tissues (including the spinal cord and sciatic nerve) were carefully separated and sampled, and then post-fixed with 4% paraformaldehyde.
[0134] 4. Clearing of neural tissue: The tissue was cleared according to the instructions of the tissue clearing kit (Cat. No.: T3740) produced by TCI.
[0135] 5. 3D Imaging and Processing of Neural Tissue
[0136] After performing z-axis multi-layer scanning on the transparent regenerated nerve tissue using a Zeiss laser confocal microscope, the regenerated nerve tissue was three-dimensionally reconstructed using ZEN software to obtain a three-dimensional image of the nerve fibers / axons in the regenerated tissue.
[0137] The three-dimensional reconstruction of normal spinal cord tissue is shown in Figure 4 and Figure 5 .Depend on Figure 4 and Figure 5 It can be seen that the confocal lens imaging results can well present three-dimensional images of nerve fibers / axons.
[0138] Comparative Example 1
[0139] Observation of the regeneration effect of spinal cord injury slices
[0140] The spinal cord of wild-type mice was frozen and sectioned (20 μm) 4 weeks after spinal cord injury and regeneration, and then immunohistochemical fluorescence staining was performed to determine the expression of the marker protein Nefh (see Figure 6 (Upper middle picture): Frozen sections break the information inertia between layers, and due to the instability of the sectioning effect, there may be situations such as roll damage that affect the final observation effect.
[0141] The homozygous mice were subjected to spinal cord injury modeling using the method of Example 1 and then regenerated for 4 weeks. The tissue was then cleared and observed under a confocal microscope. The results are shown in Figure 6 Middle and lower picture. After 3D imaging, all the information of the damaged area is recorded in the same file, and researchers can select different levels for observation according to their needs.
[0142] Comparative Example 2
[0143] Observation of the effect of regeneration after peripheral nerve tissue injury
[0144] The spinal cord of wild-type mice 4 weeks after sciatic nerve injury and regeneration was frozen and sectioned (20 μm), followed by immunohistochemical fluorescent staining to determine the expression of marker protein Nefh (see Figure 7 (Upper middle picture): Frozen sections break the information inertia between layers, and due to the instability of the sectioning effect, there may be situations such as roll damage that affect the final observation effect.
[0145] Homozygous mice in Example 1 were subjected to sciatic nerve clamp injury modeling and then regenerated for 4 weeks. Tissue clearing treatment and confocal microscopy observation were performed. The results are shown in Figure 7 Middle and lower picture. After 3D imaging, all the information of the damaged area is recorded in the same file, and researchers can select different levels for observation according to their needs.
[0146] It can be seen from the three-dimensional imaging results that the method provided by the present invention has the following advantages:
[0147] 1. Continuity and integrity
[0148] Three-dimensional imaging: It can provide a continuous three-dimensional structure of the entire tissue or organ, avoiding tissue loss and deformation during the slicing process and ensuring the integrity of the sample.
[0149] Traditional sectioning: The tissue needs to be divided into multiple thin slices, which can easily cause tissue loss or damage, especially when conducting large-area tissue research.
[0150] 2. Accuracy and resolution
[0151] Three-dimensional imaging: Using high-resolution microscopes (such as confocal microscopes, two-photon microscopes, etc.) for imaging can obtain high-resolution three-dimensional images, accurately showing the spatial distribution and structure of nerve fibers.
[0152] Traditional sectioning: The section thickness is limited and the resolution is restricted, making it difficult to accurately display the details and spatial distribution of nerve fibers.
[0153] 3. Time efficiency and automation
[0154] Three-dimensional imaging: Modern three-dimensional imaging technology is usually equipped with automated scanning and data processing systems, which can quickly acquire large-scale high-quality image data and improve research efficiency.
[0155] Traditional sectioning: requires manual sectioning, staining and observation, which is a cumbersome and time-consuming process and difficult to achieve high-throughput analysis.
[0156] 4. Data Storage and Analysis
[0157] Three-dimensional imaging: The three-dimensional data obtained can be stored, analyzed and reconstructed by computer, providing more analysis methods and visualization tools.
[0158] Traditional slicing: Data is mostly saved in the form of two-dimensional images, which makes it difficult to perform three-dimensional reconstruction and complex analysis.
[0159] Comparative Example 3
[0160] The spinal cord of the ROSA26_Nefh[KI / KI] gene mouse constructed in Example 1 was simultaneously labeled with β-Tubulin III (also used to label nerve fibers, and Nefh was not used for labeling here because there is a lack of Nefh antibodies coupled with fluorescent groups on the market).
[0161] Results Figure 8 It can be seen that Nefh-EGFP can specifically display the fibrous structure of nerve axons (left, green); antibody incubation has obvious red background nonspecific staining, and the fibrous nerve axon structure cannot be seen (right green).
[0162] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for evaluating nerve regeneration based on nerve fiber-specific fluorescence, characterized in that: The following steps are involved: After inserting the fluorescent protein encoding gene into the Nefh gene promoter of the animal genome, an animal expressing the fluorescent protein was constructed; Performing nerve injury modeling on the animal expressing the fluorescent protein, and performing repair and regeneration to obtain an animal with nerve regeneration; taking regenerated nerve tissue from the animal undergoing nerve regeneration, fixing the regenerated nerve tissue, and subjecting the regenerated nerve tissue to transparent treatment to obtain a pre-treated material; The pretreated material is subjected to bioluminescent three-dimensional imaging to obtain a three-dimensional stereogram of the regenerated nerve tissue.
2. The method for evaluating nerve regeneration according to claim 1, characterized in that: The method for constructing the animal expressing the fluorescent protein comprises constructing a recombinant Donor vector expressing the fluorescent protein; Microinjecting the recombinant Donor vector into the nucleus of the fertilized egg to obtain a recombinant fertilized egg; Transplanting the recombinant fertilized egg into the oviduct of a maternal animal via embryo, raising and giving birth to obtain F0 animals expressing fluorescent protein; The F0 animals expressing the fluorescent protein are mated and passaged to obtain offspring homozygous animals expressing the fluorescent protein.
3. The method for evaluating nerve regeneration according to claim 1 or 2, characterized in that: The fluorescent protein includes at least one of the following: green fluorescent protein, red fluorescent protein and orange fluorescent protein.
4. The method for evaluating nerve regeneration according to claim 3, characterized in that: The nucleotide sequence of the recombinant Donor vector is obtained by concatenating SEQ ID NO: 1 and SEQ ID NO:
2.
5. The method for evaluating nerve regeneration according to claim 1 or 2, characterized in that: The animals expressing fluorescent proteins also include PCR identification; The PCR identification primers include primer pair 1 and primer pair 2; The primer pair 1 comprises a forward primer having a nucleotide sequence as shown in SEQ ID NO: 3 and a reverse primer having a nucleotide sequence as shown in SEQ ID NO: 4; The primer pair 2 includes a forward primer having a nucleotide sequence as shown in SEQ ID NO:5 and a reverse primer having a nucleotide sequence as shown in SEQ ID NO:
6.
6. The nerve regeneration assessment method according to claim 1, characterized in that: The animals expressing fluorescent protein include homozygous animals expressing fluorescent protein and / or heterozygous animals expressing fluorescent protein.
7. The nerve regeneration assessment method according to claim 1, characterized in that: The method for fixing the regenerated nerve tissue from the animal with nerve regeneration is to perfuse the animal with paraformaldehyde, then peel off the skin, muscle and bone tissue under a microscope, and fix the regenerated nerve in paraformaldehyde.
8. The nerve regeneration assessment method according to claim 1, characterized in that: The nerves include the spinal cord and / or the sciatic nerve.
9. The method for evaluating nerve regeneration according to claim 1, characterized in that: The method of bioluminescent three-dimensional imaging uses a laser confocal microscope to perform z-axis multi-layer scanning on the pretreated material, and then uses ZEN software to perform three-dimensional reconstruction on the scanning results to obtain a nerve regeneration map.
10. The method for evaluating nerve regeneration according to any one of claims 1, 2, 4, 6, 7 and 9, characterized in that: The animals include mice.
Citation Information
Patent Citations
Construction method for MACF1 site-specific transgenic mice model
CN107446950A
Method for constructing animal model for ganglion cell research and method for distinguishing ganglion cell types
CN116837030A
Neuregulin for the treatment and / or prevention of tumors of the nervous system
US20210213100A1
